In this review we will summarize the current knowledge of mTOR signalling, the roles of its complexes, the mTOR involvement in the metabolism process, its relevance in ALL diseases and the status of mTOR inhibitors, reporting the most consistent results obtained from both preclinical and clinical analysis in ALL. Here, MTOR is linked to acute lymphoblastic leukemia.